Equities researchers at Credit Suisse Group started coverage on shares of Bureau Veritas (OTCMKTS:BVRDF – Get Rating) in a note issued to investors on Wednesday, TipRanks reports. The firm set a “hold” rating and a $28.50 price target on the stock. Credit Suisse Group’s price objective would suggest a potential downside of 1.09% from the company’s current price.
BVRDF has been the subject of a number of other reports. Zacks Investment Research raised shares of Bureau Veritas from a “sell” rating to a “hold” rating in a report on Friday, May 27th. Morgan Stanley boosted their price target on shares of Bureau Veritas from €30.00 ($32.26) to €30.80 ($33.12) and gave the stock an “equal weight” rating in a research note on Friday, May 6th. Finally, Barclays boosted their price target on shares of Bureau Veritas from €29.50 ($31.72) to €30.00 ($32.26) and gave the stock an “equal weight” rating in a research note on Monday, April 25th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, Bureau Veritas currently has a consensus rating of “Hold” and an average price target of $28.38.
Shares of OTCMKTS BVRDF traded down $0.11 during mid-day trading on Wednesday, reaching $28.82. 158 shares of the company were exchanged, compared to its average volume of 8,286. Bureau Veritas has a 52 week low of $26.64 and a 52 week high of $34.34. The company’s 50 day moving average price is $28.43 and its 200 day moving average price is $29.74.
Bureau Veritas SA provides laboratory testing, inspection, and certification services. It operates through six segments: Marine & Offshore; Agri-Food & Commodities; Industry; Buildings & Infrastructure; Certification; and Consumer Products. The company engages in the inspecting, analyzing, auditing, and certifying the products, assets, and management systems of its customers in relation to regulatory benchmarks or volunteers, as well as issues compliance reports.
- Get a free copy of the StockNews.com research report on Bureau Veritas (BVRDF)
- The Analysts Like The Fit Of Victoria’s Secret & Co
- Ambarella Is A Buy For Patient Investors
- Don’t Bet On A Big Rebound For Salesforce.com Stock
- 3 Specialty Retailers with Special Upside
- Is Roku (NASDAQ: ROKU) Bottoming Out?
Receive News & Ratings for Bureau Veritas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bureau Veritas and related companies with MarketBeat.com's FREE daily email newsletter.